William Waddill
Director/Board Member presso ANNEXON, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
William D.
Waddill is the founder of Square One Resources Ltd.
(founded in 2000) and Square One Finance (founded in 2000).
He held the title of Principal at both companies from 2000 to 2006.
Currently, Mr. Waddill holds the position of Independent Non-Executive Director at Arrowhead Pharmaceuticals, Inc. since 2018.
He is also a Director at Protagonist Pty Ltd., an Independent Director at Annexon, Inc. since 2021, an Independent Director at Protagonist Therapeutics, Inc. since 2016, a Director at Annexon Biosciences, Inc., and an Independent Director at Turnstone Biologics Corp.
since 2024.
In the past, Mr. Waddill served as Chairman at The Association of Bioscience Financial Officers.
From 1996 to 2000, he worked as a Senior Director-Finance & Administration at Exelixis, Inc. He also held the position of Director at Sorbent Therapeutics, Inc. and the Biotechnology Innovation Organization.
Additionally, he worked as a Principal at PricewaterhouseCoopers LLP.
From 2007 to 2014, Mr. Waddill served as the Chief Financial Officer, Treasurer & Senior VP at OncoMed Pharmaceuticals, Inc. He was the Chief Financial Officer at Medical Science Partners LP and Ilypsa, Inc. from 2006 to 2007.
He also worked as a Principal at Deloitte & Touche, Inc. From 2014 to 2016, he held the position of Chief Financial Officer, Senior VP & Treasurer at Calithera Biosciences, Inc.Mr. Waddill obtained his undergraduate degree from the University of Illinois.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 11/01/2024 | 47 870 ( 0.04% ) | 1 M $ | 31/03/2024 | |
| 01/03/2024 | 12 000 ( 0.02% ) | 347 160 $ | 31/03/2024 | |
ANNEXON, INC.
-.--% | 08/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di William Waddill
| Società | Posizione | Inizio |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Director/Board Member | 01/07/2016 |
| ARROWHEAD PHARMACEUTICALS, INC. | Director/Board Member | 01/01/2018 |
| ANNEXON, INC. | Director/Board Member | 12/08/2021 |
| TURNSTONE BIOLOGICS CORP. | Director/Board Member | 15/04/2024 |
| Annexon Biosciences, Inc. | Director/Board Member | - |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Director/Board Member | - |
Precedenti posizioni note di William Waddill
| Società | Posizione | Fine |
|---|---|---|
| CALITHERA BIOSCIENCES, INC. | Director of Finance/CFO | 31/12/2016 |
| ONCOMED PHARMACEUTICALS INC | Director of Finance/CFO | 31/03/2014 |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Director of Finance/CFO | 01/09/2007 |
Formazione di William Waddill
| University of Illinois | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| EXELIXIS, INC. | Health Technology |
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| ANNEXON, INC. | Health Technology |
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Aziende private | 9 |
|---|---|
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
Ilypsa, Inc.
Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Health Technology |
Deloitte & Touche, Inc.
 Deloitte & Touche, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte & Touche, Inc. provides accounting services. The private company is based in Calgary, Canada. | Commercial Services |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Commercial Services |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | Health Technology |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Health Technology |
| Annexon Biosciences, Inc. |
- Borsa valori
- Insiders
- William Waddill
